Article
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.
Nature communications - 17 Mar 2025
Flynn Aidan, Pattison Andrew D, Balachander Shiva, Boehm Emma, Bowen Blake, Dwight Trisha, Rossello Fernando J, Hofmann Oliver, Martelotto Luciano, Zethoven Maia, Kirschner Lawrence S, Else Tobias, Fishbein Lauren, Gill Anthony J, Tischler Arthur S, Giordano Thomas, Prodanov Tamara, Noble Jane R, Reddel Roger R, Trainer Alison H, Ghayee Hans Kumar, Bourdeau Isabelle, Elston Marianne, Ishak Diana, Ngeow Yuen Yie Joanne, Hicks Rodney J, Crona Joakim, Åkerström Tobias, Stålberg Peter, Dahia Patricia, Grimmond Sean, Clifton-Bligh Roderick, Pacak Karel, Tothill Richard W
Abstract excerpt
Hereditary SDHB-mutant pheochromocytomas (PC) and paragangliomas (PG) are rare tumours with a high propensity to metastasize although their clinical behaviour is unpredictable. To characterize the genomic landscape of these tumours and identify metastasis biomarkers, we perform multi-omic analysis on 94 tumours from 79 patients using seven molecular methods. Sympathetic (chromaffin cell) and parasympathetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
